Zanco Journal of Medical Sciences
Skip Navigation Links
Available Issues
Editorial Board
Information for Authors
Review Process
Links and Contacts
  Zanko J Med Sci:  Apr. 2017; 21 (1): 1645-1652

Clinical and pathological characteristics of primary focal segmental glomerulosclerosis in adult

Salam Fareed Wadee & Safa Ezzidin Al-Mukhtar


Background and objective: Focal segmental glomerulosclerosis shares overlapping patterns of injury with segmental consolidation and obliteration of glomerular architecture by the accumulation of collagenous extracellular matrix or by increased cellularity or both. This study aimed to investigate the patterns of primary focal segmental glomerulosclerosis in adults in Erbil. The specific objectives of this study included determining the frequency of histological variant of Focal segmental glomerulosclerosis, defining the clinical characteristics of the primary type in general and recognizing the clinical and pathological characteristics for each variant separately.

Methods: A cross-sectional, clinico-pathologic study was conducted for 50 patients attending the Nephrology Department in Erbil Teaching Hospital between March and December 2013. This study included patients of >16 years old with biopsy-proven idiopathic focal segmental glomerulosclerosis.    

Results: A total of 50 patients were enrolled into this study. The median age of patients was 33 years, ranged from 18 to 54, 31 (62%) males and 19 (38%) females. The frequency of histopathological variants was 80% not otherwise specific focal segmental glomerulosclerosis, 14% glomerular tip lesion, and 6% cellular type. Nephrotic syndrome and hypertension were the main presenting features (92% and 68%, respectively). The mean percentage of sclerosed glomeruli was 40% and the mean interstitial fibrosis and tubular atrophy was 24%.

Conclusion: A not otherwise specific variant is a common morphological lesion in many glomerular and non-glomerular diseases, and it is just like a junk drawer of multiple glomerular alterations with this common pattern of the lesion.

Keywords: Primary Focal Segmental Glomerulosclerosis; Nephrotic syndrome; Hypertension.


1. Rich A. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957; 100:173–86.

2. Churg J, Habib R, White RH. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 1970; 760:1299–302.

3. Agarwal SK, Dash SC, Tiwari SC, Bhuyan UN. "Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid." Nephron 1993; 63(2):168–71.

4. Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 1999; 34:618–25.

5. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM. Focal segmental glomerular sclerosis in adults: presentation, course and response to treatment. Am J Kidney Dis 1995; 25:534–42.

6. Thomas DB. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med 2009; 133(2):217–23.

7. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23:172–82.

8. United States Renal Data System. USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.

9. Freedman BI, Hicks PJ, Bostrom MA, Cunningham ME, Liu Y, Divers J, et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 2009; 75(7):736–45.

10. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43:368–82.

11. Ponticelli C, Glassock RJ. Treatment of Primary Glomerulonephritis. 2nd Ed.UK: Oxford University Press; 2009. p. 215–65.

 12. Friedman EA, Tao TK. Disappearance of uremia due to heroin-associated nephropathy. Am J Kidney Dis 1995; 25(5):689–93.

13. Markowitz GS, Appel GB, Fine PL. Collapsing focal segmental glomerulosclerosis following   treatment with high-dose pamidronate. J Am Soc Nephrol 2001; 12:1164–72.

14. Pascual J, Torrealba J, Myers J. Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. Osteoporos Int 2007; 1435:8–18.

15. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD. Treatment with IFN -α, -β, or -γ is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5:607–15.

16. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997; 100(1):84–92.

17. Kimmel PL, Bosch JP, Vassalotti JA. Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol 1998; 18(4):446–58.

18. Kumar V, Fausto N, Abbas A. Robbins & Cotran Pathologic Basis of Disease. 7th ed. Saunders; 2003. p. 982–3.

19. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003; 7(4):255–9.

20. Barisoni L, Kriz W, Mundel P, D’Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10(1):51–61.

21. Kriz W. The pathogenesis of “classic” focal segmental glomerulosclerosis—lessons from rat models. Nephrol Dial Transplant 2003; 18:vi39–44.

22. Howie AJ, Brewer DB. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality. J Pathol 1984; 142:205–20.

23. Howie AJ, Brewer DB. Further studies on the glomerular tip lesion: early and late stages and life table analysis. J Pathol 1985; 147:245–55. 

24. Detwiler RK, Falk RJ, Hogan SL. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 1994; 45:1416–24.

25. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713–23.

26. Post TW, Rose BD. Urinalysis in the diagnosis of renal disease. In: Curhan GC and Forman JP (Eds). Up To Date 13(2006):3.

27. Lab Tests Online. (Accessed February 10, 2012, at:

 28. National Cholesterol Education Program (Ncep) Expert Panel On Detection, E. "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation 2002; 106(25):3143–421.

29. Chobanian AV. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206–52.

30. Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 2002; 61:1567–76.

31. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'agati VD.Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis sectrum. Kidney Int 2004; 65:1690–702.

32. Chun MJ, Korbet SM, Schwartz MM, Korbert SM and Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004; 15:2169–77. 

33. Arias LF, Jiminez CA, Arroyave MJ. Histologic variants of primary focal segmental glomerulosclerosis: presentation and outcome. J Bras Nefrol 2013; 35(2):112–9.

34. Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney Int Suppl 2003; 63:S43–9.

35. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81:440–7.

36. Gutierrez-Millet V, Nieto J, Praga M, Usera G, Martinez MA, Morales JM. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys. Arch Intern Med 1986; 146:705–9.

37. Praga M, Morales E, Herrero JC. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 1999; 33:52–8.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.